These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1236 related articles for article (PubMed ID: 14671189)

  • 21. Endogenous inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome.
    Walker BR; Rodin A; Taylor NF; Clayton RN
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):77-80. PubMed ID: 10651756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome.
    Blumenfeld Z; Kaidar G; Zuckerman-Levin N; Dumin E; Knopf C; Hochberg Z
    Clin Med Insights Reprod Health; 2016; 10():9-13. PubMed ID: 27168731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5α-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Wu C; Wei K; Jiang Z
    Reprod Biol Endocrinol; 2017 Mar; 15(1):21. PubMed ID: 28347315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local Regeneration of Cortisol by 11β-HSD1 Contributes to Insulin Resistance of the Granulosa Cells in PCOS.
    Zhu Q; Zuo R; He Y; Wang Y; Chen ZJ; Sun Y; Sun K
    J Clin Endocrinol Metab; 2016 May; 101(5):2168-77. PubMed ID: 26934392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase.
    Rodin A; Thakkar H; Taylor N; Clayton R
    N Engl J Med; 1994 Feb; 330(7):460-5. PubMed ID: 8289851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls.
    Gambineri A; Fanelli F; Tomassoni F; Munarini A; Pagotto U; Andrew R; Walker BR; Pasquali R
    Eur J Endocrinol; 2014 Jul; 171(1):47-57. PubMed ID: 24743397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian 11β-hydroxysteroid dehydrogenase (11βHSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens.
    Michael AE; Glenn C; Wood PJ; Webb RJ; Pellatt L; Mason HD
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3375-83. PubMed ID: 23678035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
    Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of 11β-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects.
    Li S; Tao T; Wang L; Mao X; Zheng J; Zhao A; Liu W
    Horm Metab Res; 2013 Oct; 45(11):802-7. PubMed ID: 23979790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children.
    Remer T; Maser-Gluth C; Boye KR; Hartmann MF; Heinze E; Wudy SA
    Steroids; 2006 Jul; 71(7):591-8. PubMed ID: 16616286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in the urinary excretion rates of cortisol and androgen metabolites.
    Shamim W; Yousufuddin M; Bakhai A; Coats AJ; Honour JW
    Ann Clin Biochem; 2000 Nov; 37 ( Pt 6)():770-4. PubMed ID: 11085621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
    Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.
    Monder C; Shackleton CH; Bradlow HL; New MI; Stoner E; Iohan F; Lakshmi V
    J Clin Endocrinol Metab; 1986 Sep; 63(3):550-7. PubMed ID: 3460996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortisol metabolism in depressed patients and healthy controls.
    Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
    Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.